Cardiopulmonary resuscitation with balloon occlusion of the descending aorta for hospitalized patients
Official title: CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta
Run by Insel Gruppe AG, University Hospital Bern · NCT07434726 · Data updated 2026-11-12
This trial will test whether adding a balloon occlusion of the descending aorta (REBOA) to standard ACLS helps people having an in-hospital cardiac arrest regain and keep a pulse.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 98 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | April 14, 2026 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07434726 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients with ongoing in-hospital cardiac arrest (including those who re-arrest after OHCA in the ED) who have any electrical cardiac activity on initial rhythm analysis and in whom femoral arterial access can be achieved while resuscitation continues.
✕Probably not a fit
Patients with asystole on initial rhythm, traumatic arrest, known DNR orders, pregnancy, prohibitive aortic pathology, or inability to obtain femoral access are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who have an in-hospital cardiac arrest outside the operating room, ICU, or cath lab and who meet inclusion criteria will be randomized during active resuscitation to receive standard advanced cardiac life support (ACLS) alone or ACLS plus placement of a REBOA catheter to occlude the descending thoracic aorta. A research team deploys simultaneously with the clinical resuscitation team, and femoral artery access must be obtained to allow randomization. The primary focus is frequency of sustained return of spontaneous circulation (ROSC); secondary care, imaging contrast risks, and exclusion criteria such as asystole, pregnancy, known DNR, traumatic arrest, or prohibitive aortic pathology are pre-specified. The intervention is performed in-hospital with immediate monitoring and standard post-ROSC care.
Why it matters
Potential benefit: If successful, adding REBOA could increase the chances of sustained return of circulation during in-hospital cardiac arrest and potentially improve survival and neurologic outcomes.
How similar studies have gone: REBOA has shown benefit in traumatic hemorrhage and some animal and small human studies suggest it can raise coronary perfusion during CPR, but randomized human data for nontraumatic cardiac arrest is limited and this application is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * patients suffering from in hospital cardiac arrest (IHCA), including patients with out of hospital cardiac arrest (OHCA) and return of spontaneous circulation (ROSC), transported to the emergency department, where they suffer a second arrest (IHCA) * successful placement of a femoral artery introducer sheath * any electrical cardiac activity seen in the initial rhythm analysis * ongoing effort of resuscitation as determined by study-independent resuscitation lead Exclusion criteria: * IHCA in the operating room, on intensive care unit or in the cardiac catheter laboratory * hospital visitors suffering from cardiac arrest * asystole seen in the initial rhythm analysis * (presumed) age under 18 years * known "do not resuscitate"-order * known or obvious pregnancy * traumatic cardiac arrest * known aortic pathologies that render cannulation impossible * known allergies to radiographic contrast agents
Where it's running
-
Inselspital University Hospital Bern
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Tanja Birrenbach, MD, MME — Inselspital University Hospital Bern
- Study coordinator: Tanja Birrenbach, MD, MME
- Email: tanja.birrenbach@insel.ch
- Phone: +41 31 632 57 01
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Digital serious game to improve critical care nurses' targeted temperature management skills and situational awareness.
We will test whether adding a digital serious game to regular lectures helps adult ICU nurses learn targeted temperature management and improve situational awareness.
-
Plasma proteins, metabolites, and platelet changes in extracorporeal CPR for cardiac arrest patients
This project will test whether patterns in blood proteins, small molecules, and platelet shape changes can help identify which adults with cardiac arrest might benefit from extracorporeal CPR.
-
Targeted Temperature Management at 33°C for in-hospital cardiac arrest
This trial tests whether cooling patients who remain unconscious after a resuscitated in-hospital cardiac arrest to 33°C improves survival with good brain function compared to keeping a normal, controlled temperature.
-
Goal-directed neuroprotection bundle for adults after cardiac arrest
This trial will test whether a goal-directed bundle of treatments (temperature, breathing gases, position, blood pressure, glucose, sodium and lactate control) helps adults who are unconscious after return of circulation from cardiac arrest recover their brain function better than usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.